selinexor,Ruxolitinib
karyopharm therapeutics,novartis,incyte
['selinexor']
karyopharm announces presentation of updated phase 1 selinexor data in patients with treatment-na ve myelofibrosis at aacr 2023 #stocksoftheday #stockalert #stocknews #phase1 
Find the most important news and press releases about U.S. publicly-traded companies in real-time and stay ahead of the game!